Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:15 pm Sale | 2026-06-30 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Vivo Opportunity Fund Holdings, L.P. | 4,856,259 9.990% | -1,239,916 (-20.34%) | Filing History |
| 2026-08-14 4:11 pm Sale | 2026-06-30 | 13G | TENAX THERAPEUTICS INC PAR TENX | Vivo Opportunity Fund Holdings, L.P. | 3,458,327 9.000% | -2,791,663 (-44.67%) | Filing History |
| 2026-08-14 4:07 pm Sale | 2026-06-30 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Vivo Opportunity Fund Holdings, L.P. | 22,637,108 9.990% | -3,293,892 (-12.70%) | Filing History |
| 2026-08-14 4:03 pm Sale | 2026-06-30 | 13G | PASITHEA THERAPEUTICS CORP COM KTTA | Vivo Opportunity Fund Holdings, L.P. | 9,286,738 9.990% | -8,273,729 (-47.12%) | Filing History |
| 2026-08-14 3:59 pm Sale | 2026-06-30 | 13G | COMPASS THERAPEUTICS INC CMPX | Vivo Opportunity Fund Holdings, L.P. | 7,207,573 4.000% | -1,788,406 (-19.88%) | Filing History |
| 2026-08-14 3:54 pm Sale | 2026-06-30 | 13G | CLENE INC CLNN | Vivo Opportunity Fund Holdings, L.P. | 1,321,675 9.990% | -564,794 (-29.94%) | Filing History |
| 2026-08-04 2:48 pm Purchase | 2026-07-28 | 13G | ENTERA BIO LTD SHS ENTX | Vivo Opportunity Fund Holdings, L.P. | 11,817,401 6.900% | 11,817,401 (New Position) | Filing History |
| 2026-07-08 4:30 pm Purchase | 2026-07-06 | 13G | ACHIEVE LIFE SCIENCES INC ACHV | Vivo Opportunity Fund Holdings, L.P. | 5,305,640 5.000% | 5,305,640 (New Position) | Filing History |
| 2026-06-10 9:32 pm Purchase | 2026-05-19 | 13D | INMED PHARMACEUTICALS INC INM | Vivo Opportunity Fund Holdings, L.P. | 718,444 21.700% | 718,444 (New Position) | Filing History |
| 2026-05-12 9:48 pm Sale | 2026-03-31 | 13G | ACLARIS THERAPEUTICS INC ACRS | Vivo Opportunity Fund Holdings, L.P. | 5,966,370 4.300% | -1,988,790 (-25.00%) | Filing History |
| 2026-05-12 9:45 pm Purchase | 2026-03-31 | 13G | CLENE INC CLNN | Vivo Opportunity Fund Holdings, L.P. | 1,886,469 9.990% | 1,261,469 (+201.84%) | Filing History |
| 2026-05-12 9:44 pm Sale | 2026-03-31 | 13G | DBV TECHNOLOGIES S.A. ADR DBVT | Vivo Opportunity Fund Holdings, L.P. | 11,820,005 4.000% | -3,865,945 (-24.65%) | Filing History |
| 2026-05-12 9:44 pm Purchase | 2026-03-31 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Vivo Opportunity Fund Holdings, L.P. | 504,645 5.200% | 50,461 (+11.11%) | Filing History |
| 2026-03-13 4:02 pm Purchase | 2026-03-10 | 13G | AN2 THERAPEUTICS INC ANTX | Vivo Opportunity Fund Holdings, L.P. | 2,864,346 8.000% | 2,864,346 (New Position) | Filing History |
| 2026-02-20 4:43 pm Purchase | 2026-02-17 | 13G | IMMUNIC INC IMUX | Vivo Opportunity Fund Holdings, L.P. | 2,912,691 9.990% | 2,912,691 (New Position) | Filing History |
| 2026-02-13 6:11 pm Purchase | 2025-01-31 | 13G | TERNS PHARMACEUTICALS INC TERN | Vivo Opportunity Fund Holdings, L.P. | 2,700,615 2.500% | 2,700,615 (New Position) | Filing History |
| 2026-02-13 6:11 pm Sale | 2026-01-12 | 13G | DBV TECHNOLOGIES S.A. ADR DBVT | Vivo Opportunity Fund Holdings, L.P. | 15,685,950 5.700% | -4,672,520 (-22.95%) | Filing History |
| 2026-02-13 6:11 pm Sale | 2026-01-07 | 13G | CIDARA THERAPEUTICS INC NE CDTX | Vivo Opportunity Fund Holdings, L.P. | 0 0.000% | -1,175,796 (Position Closed) | Filing History |
| 2026-02-13 6:11 pm Purchase | 2025-12-31 | 13G | CAMP4 THERAPEUTICS CORP COM CAMP | Vivo Opportunity Fund Holdings, L.P. | 3,856,991 7.400% | 295,198 (+8.29%) | Filing History |
| 2025-12-31 4:30 pm Purchase | 2025-12-23 | 13G | MINERVA NEUROSCIENCES INC NERV | Vivo Opportunity Fund Holdings, L.P. | 8,591,572 9.990% | 8,591,572 (New Position) | Filing History |